Kazakhstan vs Syria: Number of clinical trials
Kazakhstan
13
in 2024
Syria
15
in 2024
Kazakhstan rank
63rd
Syria rank
62nd
Number of clinical trials over time
- Kazakhstan
- Syria
How they compare
Syria currently reports 15 against 13 in Kazakhstan, a difference of 2.
That makes Syria's figure about 1.2 times Kazakhstan's.
Across all 12 years both countries report, Syria has been ahead every year.
Kazakhstan ranks 63rd and Syria ranks 62nd of 153 countries.
Syria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Kazakhstan | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.71 | 12.29 | 9.57 | Syria |
| 2020s | 13.4 | 25 | 11.6 | Syria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of clinical trials, Kazakhstan or Syria?
- Syria, at 15 against 13 in Kazakhstan as of 2024.
- What is the difference in number of clinical trials between Kazakhstan and Syria?
- 2, with Syria ahead.
- How many years of comparable data are there for Kazakhstan and Syria?
- 12 years are reported by both, from 2012 to 2024.
- How do Kazakhstan and Syria rank globally for number of clinical trials?
- Kazakhstan ranks 63rd and Syria ranks 62nd of 153 countries.
- Where does this data come from?
- Our World in Data, published as Number of clinical trials. Statizoid refreshes it automatically from the source and publishes the full history for both places.